These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3383549)

  • 81. Antibacterial properties of alafosfalin combined with cephalexin.
    Atherton FR; Hall MJ; Hassall CH; Holmes SW; Lambert RW; Lloyd WJ; Nisbet LJ; Ringrose PS; Westmacott D
    Antimicrob Agents Chemother; 1981 Oct; 20(4):470-6. PubMed ID: 7044291
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Method of evaluating effects of antibiotics on bacterial biofilm.
    Prosser BL; Taylor D; Dix BA; Cleeland R
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1502-6. PubMed ID: 3435100
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Synergistic effects of ampicillin-aminoglycoside combinations on group B streptococci.
    Cooper MD; Keeney RE; Lyons SF; Cheatle EL
    Antimicrob Agents Chemother; 1979 Mar; 15(3):484-6. PubMed ID: 380461
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Patterns of multiple resistance to antibiotics in gram-negative bacteria demonstrated by factor analysis.
    Leibovici L; Wysenbeek AJ; Konisberger H; Samra Z; Pitlik SD; Drucker M
    Eur J Clin Microbiol Infect Dis; 1992 Sep; 11(9):782-8. PubMed ID: 1468416
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans.
    Barza M; Giuliano M; Jacobus NV; Gorbach SL
    Antimicrob Agents Chemother; 1987 May; 31(5):723-7. PubMed ID: 3496848
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Activity of cefotiam in combination with beta-lactam antibiotics on enterobacterial hospital strains.
    Vanhoof R; Hubrechts JM; Nyssen HJ; Nulens E; Leger J; de Schepper N; Kupperberg E; Couvreur ML
    Pharm Weekbl Sci; 1990 Jun; 12(3):104-6. PubMed ID: 2371139
    [TBL] [Abstract][Full Text] [Related]  

  • 87. 7-Hydroxytropolone: an inhibitor of aminoglycoside-2"-O-adenylyltransferase.
    Allen NE; Alborn WE; Hobbs JN; Kirst HA
    Antimicrob Agents Chemother; 1982 Nov; 22(5):824-31. PubMed ID: 6185088
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Antimicrobial susceptibility of bifidobacteria.
    Yazid AM; Ali AM; Shuhaimi M; Kalaivaani V; Rokiah MY; Reezal A
    Lett Appl Microbiol; 2000 Jul; 31(1):57-62. PubMed ID: 10886616
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Enhancing uptake of antibiotics into Gram-negative bacteria using nonribosome-targeting aminoglycoside-based adjuvants.
    Schweizer F
    Future Med Chem; 2019 Jul; 11(13):1519-1522. PubMed ID: 31469333
    [No Abstract]   [Full Text] [Related]  

  • 90. Theoretical and practical study of the cefoxitin-Escherichia coli PBP5 complex interaction by molecular dynamics to obtain computational prototype of antimicrobial susceptibility to Gram negative bacteria.
    Silva TBBD; Monteiro MC; Borges RDS; Barros TG; Carneiro ADS; Barros CAL
    Chem Biol Drug Des; 2020 Oct; 96(4):1095-1102. PubMed ID: 29938904
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions.
    Das Gupta V; Stewart KR
    J Clin Hosp Pharm; 1985 Mar; 10(1):67-72. PubMed ID: 3998183
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinical pharmacology of cefazolin in calves.
    Soback S; Bor A; Ziv G
    Zentralbl Veterinarmed A; 1987 Jan; 34(1):25-32. PubMed ID: 3105197
    [No Abstract]   [Full Text] [Related]  

  • 93. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Amdinocillin: a novel penicillin. Antibacterial activity, pharmacology and clinical use.
    Neu HC
    Pharmacotherapy; 1985; 5(1):1-10. PubMed ID: 3885172
    [TBL] [Abstract][Full Text] [Related]  

  • 95. In vitro activity of amdinocillin in combination with other beta-lactam antibiotics against aminoglycoside-susceptible and resistant gram-negative bacteria.
    Nachamkin I; Gibson G; Sawyer K; Samel C; Skalina D
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):87-96. PubMed ID: 3383549
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillin.
    Isenberg HD; Tilton RC; Barry AL; Beskid G; Cleeland R; Fallat V; Murray PR; Pierson C; Squires E
    J Clin Microbiol; 1987 Jul; 25(7):1195-200. PubMed ID: 3611312
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.
    Cleeland R; Squires E
    Am J Med; 1983 Aug; 75(2A):21-9. PubMed ID: 6311002
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.